Regulacje i polityka gospodarcza · 22/12/2025

HRSA Adds Metachromatic Leukodystrophy to Recommended Uniform Screening Panel

The Health Resources and Services Administration (HRSA) has added Metachromatic Leukodystrophy (MLD) to the Recommended Uniform Screening Panel (RUSP) after considering public comments and evidence-based reports, with the Secretary of Health and Human Services (HHS) accepting the recommendation.